Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Financing channel feed
Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval
7 months ago
Startups
Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis
7 months ago
Startups
Exclusive: Tiny startup with big vision to extend healthspan by 20 years says it discovered an ‘Atlas of Rejuvenation’
7 months ago
Startups
Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech
7 months ago
Startups
Upstream and CAMP4 target $182M, $67M IPOs
7 months ago
Startups
Biotech's third quarter was relatively bright — with a few caveats
7 months ago
Startups
Deals
Flagship partners with key Singapore R&D agency as it boosts APAC investment
7 months ago
Startups
Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers
7 months ago
R&D
Investor Kurma Partners raises €140M for latest Europe-focused biotech fund
7 months ago
Startups
Resolution raises $85M to test macrophage therapies in end-stage liver disease
7 months ago
Cell/Gene Tx
Septerna files for Nasdaq listing as biotech IPOs come to life
7 months ago
Startups
Frazier adds $630M to public fund to 'take advantage of market volatility'
7 months ago
Triveni to take experimental eczema drug to the clinic, backed by new $115M financing round
7 months ago
Startups
UK biotech bags $43M in Series A to move Huntington's drug into first human study
7 months ago
R&D
23andMe CEO says she is no longer open to outside takeover offers
7 months ago
Deals
Pharma
Ron Renaud's new obesity biotech, Kailera, has $400M to go straight to Phase 3
7 months ago
Startups
China
DCVC Bio reels in $400M third fund
7 months ago
Startups
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
7 months ago
Startups
Pharma
The worst is over for digital health funding, PitchBook report says
7 months ago
Health Tech
Insilico Medicine, an early force in AI-driven drug R&D, lets IPO plans peter out for second year in a row
7 months ago
Startups
China
ARCH, biotech's star slugger, snags another $3B for 13th fund
7 months ago
Startups
Flagship launches startup to design and make lipid nanoparticles for genetic medicines
7 months ago
Startups
Manufacturing
Barcelona VC firm Asabys raises second fund, adding to Europe’s biotech funding scene
7 months ago
Startups
Next-gen obesity biotech BioAge Labs to raise $198M in IPO
7 months ago
Startups
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page